CMP: 664

Merck Ltd. manufactures pharmaceutical drugs, reagents, bulk drugs, diagnostic equipment, pigments, chemicals, and pesticides. The Company's major products include neurotropic specialties such as encephabol, anti-psychotics such as lithocarb and vitamin formulations such as neurobion, polybion, multiboonata, e tc.

Merck is a good bet in mid-cap space trading at a P/E of 15. It runs at Zero debt with 52 Crores cash in hand. Revenues have risen from 315 Crores to 560 Crores in the last 5 years. Profits have stayed around 60 Crores in the last 5 years. Profit margins have dipped from 22% to 11% over the last 5 years. Recent quarter results have bounced back well. Buy and book profits when Nifty peaks.